Monitoring eye pressure matters

Elevated eye pressure is the primary risk factor of Glaucoma, the leading cause of irreversible blindness worldwide 

3 million people are currently being treated for Glaucoma in the U.S., while an estimated 50% of Glaucoma sufferers are undiagnosed ​​

​Reducing eye pressure is the only known way of slowing down or stopping the progression of Glaucoma

By 2020, an estimated 80 million people will suffer from Glaucoma worldwide; that number is expected to reach 112 million by 2040

Better Informed Decisions

 for Diagnosis and Treatment of Glaucoma

How is Glaucoma treated?

With prescription eye drops that lower eye pressure and prevent further damage to the optic nerve

Patients visit the eye doctor for a Glaucoma eye exam and are prescribed medication.

To make sure their medication is working, they return a few months later and the process repeats.

For every 1mmHg reduction in eye pressure, the risk of optic nerve damage decreases by 11%

What is the biggest obstacle to Glaucoma Treatment?

​

Current methods of measuring eye pressure only give doctors one data point in time, which prevents them from fully understanding a patient's condition

A 2015 study* reported after 20 years of Glaucoma damage, 38.1% of patients were blind in one eye and 13.5% of patients were blind in both eyes

​

​

​

*Susanna, R., De Moraes, C. G., Cioffi, G. A., & Ritch, R. (2015). Why do people (still) go blind from glaucoma?. Translational vision science & technology, 4(2), 1-1.

Your Vision in Your Hands

Smartlens is an intuitive and accurate way of measuring eye pressure and its fluctuations throughout the day, the primary risk factors for Glaucoma

Smartlens has created the first electronic-free soft contact lens that accurately measures eye pressure and its fluctuations throughout the day, giving doctors and patients a better tool for Glaucoma diagnosis and management​